Our mission is to provide our clients with non-clinical development and clinical trial oversight solutions to enable their innovative products to enter clinical development successfully and rapidly, through the delivery of high quality, well planned and proactive operational and regulatory support

Our history

Leads To Development (L2D) is a privately owned organisation that was formed in 2009 as a high value service company that provides support to clients developing innovative therapies. Based in Paris, France, L2D’s international team provides hands-on scientific, regulatory and project management expertise across all stages of drug development.

Historically, L2D’s core expertise centred on CMC and non-clinical aspects of drug development, primarily focused on the earlier stages, from discovery to the first tests in humans. Today, we support our clients throughout their entire development programmes, up to licensure application, and offer a widened range of services, including clinical trial oversight. Our know-how spans multiple indications and therapeutic product classes, from new chemical entities (small molecules), to peptides, biologics and implantable medical devices.

The expertise we have built allows our clients to increase the chances of successfully developing their promising new drugs, whilst reducing the time taken to reach their development milestones.

Our team

Claire DZIENGELEWSKI
Project Manager
Ph.D. in Molecular and Cellular Biology

Davy BAUDELET
Senior Project Manager
Ph.D. in Medicinal Chemistry

Lucie DE BEAUCHAMP
Project Manager
Ph.D. in Haemato-oncology

Leila LAREDJ
Senior Project Manager, Team Leader
Ph.D. in Molecular Genetics

Davei ATALLA
Project Manager
Pharm.D.

Marion LANDRY
Senior Project Manager, Quality Assurance Manager
Pharm.D., Ph.D. in Human and Nanomaterial Toxicology

Joëlle SALAMEH
Project Manager
Ph.D. in Cellular and Molecular Physiopathology

Vincent DUBOIS
Managing Director, Head of Production
Ph.D. in Cell Biology and Biochemistry

Charlie QUESTEL
Project Manager
Ph.D. in Molecular and Biological Electrochemistry

Jonathan KEARSEY
Managing Director
Ph.D. in Molecular Biology

Julien Massiot
Senior Project Manager
Ph.D. in Pharmaceutical Nanotechnology

Candice MARION
Senior Project Manager, Team Leader
Ph.D. in Neuroendocrinology

Rachael TAITT
Project Manager
Ph.D. in Chemistry and Nanotechnologies

Hugh GIFFNEY
Project Manager
Ph.D. in Immunology and Drug Delivery

Nathalie VALLE
Head of Quality Assurance
Pharm.D.

Stephanie DOWELL
Business Development Manager
Ph.D. in Molecular Pathology

Nadège ANTOINE
Office Manager
Diploma in Business and Administration